United States

Rhoen Klinikum AG (RHKG.DE)

RHKG.DE on Xetra

5:29am EDT
Change (% chg)

€-0.00 (-0.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for RHKG.DE


Rhoen Klinikum AG is a Germany-based provider of health care services. It operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand... (more)


Beta: -0.00
Market Cap(Mil.): €1,704.19
Shares Outstanding(Mil.): 66.96
Dividend: 0.80
Yield (%): 3.14


  RHKG.DE Industry Sector
P/E (TTM): 16.84 32.67 29.98
EPS (TTM): 1.51 -- --
ROI: 9.31 5.67 13.08
ROE: 9.36 8.92 14.23

BRIEF-Asklepios owner hikes stake in Rhoen-Klinikum to more than 20 pct

* Says Asklepios owner Broermann's holding in Rhoen rises to 20.2 percent from 17.6 percent Source text for Eikon: Further company coverage:

Mar 06 2017

BRIEF-Rhoen Klinikum FY net consolidated profit was at EUR 58.6 mln

* FY corporate revenues stood at 1.18 billion euros ($1.25 billion) with earnings before interest, taxes, depreciation and amortisation (EBITDA) amounting to 156.9 million euros

Feb 24 2017

BRIEF-Rhoen-Klinikum reduces size of management board

* To reduce size of management board from five to three members by revoking appointment of Martin Menger (operative business) and Jens-Peter Neumann (finance) to management board

Feb 23 2017

Rhoen Klinikum's management board to be reduced

Feb 16 A committee of Rhoen Klinikum's supervisory board on Thursday proposed to cut the number of management board members and remove two key executives, finance chief Jens-Peter Neumann and chief operating officer Martin Menger.

Feb 16 2017

BRIEF-Rhoen Klinikum: removal of management board members Martin Menger and Jens-Peter Neumann

* Personnel committee of the supervisory board recommends reducing the management board by removing management board members Martin Menger and Jens-Peter Neumann

Feb 16 2017

BRIEF-Rhoen Klinikum: value adjustment in connection with financial investment in MIT GmbH

* Value adjustment in connection with financial investment in mit gmbh in amount of approx. 35.5 million euros ($37.66 million)

Feb 14 2017

Rhoen Klinikum appoints Stephan Holzinger as chief executive

FRANKFURT, Jan 20 Rhoen Klinikum appointed Stephan Holzinger as its chief executive on Friday for a five-year term from Feb. 1.

Jan 20 2017

BRIEF-Rhoen Klinikum says plans to appoint Stephan Holzinger as new CEO

* dgap-adhoc: rhön-klinikum ag: decision making process of supervisory board of rhön- klinikum concerning reorganization of management board

Jan 19 2017

BRIEF-Rhoen Klinikum: significant structural burdens on FY 2017 results

* Management board expects since today significant structural burdens on results in a range of low to middle two digit millions for current financial year 2017

Jan 19 2017

BRIEF-Rhoen Klinikum sees regulatory obstacles, confirms outlook

* EBITDA in amount of euro 131.5 million includes dissolving provisions of euro 41 million

Nov 04 2016

More From Around the Web

Earnings vs. Estimates